vs

Side-by-side financial comparison of Steel Dynamics (STLD) and TENET HEALTHCARE CORP (THC). Click either name above to swap in a different company.

TENET HEALTHCARE CORP is the larger business by last-quarter revenue ($5.5B vs $5.2B, roughly 1.1× Steel Dynamics). TENET HEALTHCARE CORP runs the higher net margin — 11.7% vs 7.7%, a 4.0% gap on every dollar of revenue. On growth, Steel Dynamics posted the faster year-over-year revenue change (17.9% vs 9.0%). Over the past eight quarters, Steel Dynamics's revenue compounded faster (6.0% CAGR vs 1.5%).

Steel Dynamics, Inc. (SDI) is an American steel producer based in Fort Wayne, Indiana. With a production capacity of 13 million tons of steel, the company is the third largest producer of carbon steel products in the United States. It is among the most profitable American steel companies in terms of profit margins and operating margin per ton. Based on its 2021 revenue, the company ranked 196th on the 2022 edition of the Fortune 500.

Tenet Healthcare Corporation is an American for-profit multinational healthcare services company based in Dallas. Through its brands, subsidiaries, joint ventures, and partnerships including United Surgical Partners International (USPI), the company operates 65 hospitals and over 450 healthcare facilities. Tenet also runs Conifer Health Solutions, which provides healthcare support services to health systems and other clients.

STLD vs THC — Head-to-Head

Bigger by revenue
THC
THC
1.1× larger
THC
$5.5B
$5.2B
STLD
Growing faster (revenue YoY)
STLD
STLD
+8.9% gap
STLD
17.9%
9.0%
THC
Higher net margin
THC
THC
4.0% more per $
THC
11.7%
7.7%
STLD
Faster 2-yr revenue CAGR
STLD
STLD
Annualised
STLD
6.0%
1.5%
THC

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
STLD
STLD
THC
THC
Revenue
$5.2B
$5.5B
Net Profit
$400.1M
$644.0M
Gross Margin
14.7%
Operating Margin
10.3%
15.4%
Net Margin
7.7%
11.7%
Revenue YoY
17.9%
9.0%
Net Profit YoY
51.3%
12.6%
EPS (diluted)
$2.78
$4.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STLD
STLD
THC
THC
Q1 26
$5.2B
Q4 25
$4.4B
$5.5B
Q3 25
$4.8B
$5.3B
Q2 25
$4.6B
$5.3B
Q1 25
$4.4B
$5.2B
Q4 24
$3.9B
$5.1B
Q3 24
$4.3B
$5.1B
Q2 24
$4.6B
$5.1B
Net Profit
STLD
STLD
THC
THC
Q1 26
$400.1M
Q4 25
$266.0M
$644.0M
Q3 25
$403.7M
$579.0M
Q2 25
$298.7M
$522.0M
Q1 25
$217.2M
$622.0M
Q4 24
$207.3M
$572.0M
Q3 24
$317.8M
$681.0M
Q2 24
$428.0M
$477.0M
Gross Margin
STLD
STLD
THC
THC
Q1 26
14.7%
Q4 25
12.0%
Q3 25
15.7%
Q2 25
13.5%
Q1 25
11.1%
Q4 24
11.4%
Q3 24
13.9%
Q2 24
16.7%
Operating Margin
STLD
STLD
THC
THC
Q1 26
10.3%
Q4 25
7.0%
15.4%
Q3 25
10.5%
16.8%
Q2 25
8.4%
15.6%
Q1 25
6.3%
18.1%
Q4 24
6.1%
16.2%
Q3 24
9.1%
21.3%
Q2 24
12.1%
14.9%
Net Margin
STLD
STLD
THC
THC
Q1 26
7.7%
Q4 25
6.0%
11.7%
Q3 25
8.4%
10.9%
Q2 25
6.5%
9.9%
Q1 25
5.0%
11.9%
Q4 24
5.4%
11.3%
Q3 24
7.3%
13.3%
Q2 24
9.2%
9.3%
EPS (diluted)
STLD
STLD
THC
THC
Q1 26
$2.78
Q4 25
$1.80
$4.22
Q3 25
$2.74
$3.86
Q2 25
$2.01
$3.14
Q1 25
$1.44
$4.27
Q4 24
$1.40
$3.79
Q3 24
$2.05
$4.89
Q2 24
$2.72
$2.64

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STLD
STLD
THC
THC
Cash + ST InvestmentsLiquidity on hand
$556.5M
$2.9B
Total DebtLower is stronger
$4.2B
$13.1B
Stockholders' EquityBook value
$9.0B
$4.2B
Total Assets
$16.7B
$29.7B
Debt / EquityLower = less leverage
0.47×
3.10×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STLD
STLD
THC
THC
Q1 26
$556.5M
Q4 25
$769.9M
$2.9B
Q3 25
$770.4M
$3.0B
Q2 25
$497.6M
$2.6B
Q1 25
$1.2B
$3.0B
Q4 24
$737.3M
$3.0B
Q3 24
$1.7B
$4.1B
Q2 24
$1.2B
$2.9B
Total Debt
STLD
STLD
THC
THC
Q1 26
$4.2B
Q4 25
$4.2B
$13.1B
Q3 25
$3.8B
$13.1B
Q2 25
$3.8B
$13.1B
Q1 25
$4.2B
$13.1B
Q4 24
$3.2B
$13.1B
Q3 24
$3.7B
$12.8B
Q2 24
$3.1B
$12.8B
Stockholders' Equity
STLD
STLD
THC
THC
Q1 26
$9.0B
Q4 25
$9.0B
$4.2B
Q3 25
$9.0B
$4.0B
Q2 25
$8.9B
$3.7B
Q1 25
$8.8B
$4.2B
Q4 24
$8.9B
$4.2B
Q3 24
$9.1B
$3.8B
Q2 24
$9.1B
$3.5B
Total Assets
STLD
STLD
THC
THC
Q1 26
$16.7B
Q4 25
$16.4B
$29.7B
Q3 25
$16.0B
$29.4B
Q2 25
$15.5B
$28.7B
Q1 25
$15.9B
$29.2B
Q4 24
$14.9B
$28.9B
Q3 24
$15.7B
$29.4B
Q2 24
$15.1B
$29.3B
Debt / Equity
STLD
STLD
THC
THC
Q1 26
0.47×
Q4 25
0.47×
3.10×
Q3 25
0.42×
3.26×
Q2 25
0.43×
3.49×
Q1 25
0.48×
3.13×
Q4 24
0.36×
3.14×
Q3 24
0.41×
3.33×
Q2 24
0.34×
3.67×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STLD
STLD
THC
THC
Operating Cash FlowLast quarter
$148.3M
$731.0M
Free Cash FlowOCF − Capex
$367.0M
FCF MarginFCF / Revenue
6.6%
Capex IntensityCapex / Revenue
6.6%
Cash ConversionOCF / Net Profit
0.37×
1.14×
TTM Free Cash FlowTrailing 4 quarters
$2.5B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STLD
STLD
THC
THC
Q1 26
$148.3M
Q4 25
$272.7M
$731.0M
Q3 25
$722.6M
$1.1B
Q2 25
$301.6M
$936.0M
Q1 25
$152.6M
$815.0M
Q4 24
$346.9M
$-331.0M
Q3 24
$759.9M
$1.0B
Q2 24
$382.6M
$747.0M
Free Cash Flow
STLD
STLD
THC
THC
Q1 26
Q4 25
$84.2M
$367.0M
Q3 25
$556.9M
$778.0M
Q2 25
$13.3M
$743.0M
Q1 25
$-152.9M
$642.0M
Q4 24
$-106.3M
$-661.0M
Q3 24
$138.5M
$829.0M
Q2 24
$-36.6M
$602.0M
FCF Margin
STLD
STLD
THC
THC
Q1 26
Q4 25
1.9%
6.6%
Q3 25
11.5%
14.7%
Q2 25
0.3%
14.1%
Q1 25
-3.5%
12.3%
Q4 24
-2.7%
-13.0%
Q3 24
3.2%
16.2%
Q2 24
-0.8%
11.8%
Capex Intensity
STLD
STLD
THC
THC
Q1 26
Q4 25
4.3%
6.6%
Q3 25
3.4%
5.3%
Q2 25
6.3%
3.7%
Q1 25
7.0%
3.3%
Q4 24
11.7%
6.5%
Q3 24
14.3%
4.2%
Q2 24
9.0%
2.8%
Cash Conversion
STLD
STLD
THC
THC
Q1 26
0.37×
Q4 25
1.03×
1.14×
Q3 25
1.79×
1.83×
Q2 25
1.01×
1.79×
Q1 25
0.70×
1.31×
Q4 24
1.67×
-0.58×
Q3 24
2.39×
1.53×
Q2 24
0.89×
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

STLD
STLD

Steel$3.5B68%
Metals Recycling$593.2M11%
Other$490.1M9%
Steel Fabrication$355.4M7%
Aluminum$227.4M4%

THC
THC

Other$2.9B52%
Health Care Patient Service$1.4B25%
Equity Method Investment Nonconsolidated Investee Or Group Of Investees$1.2B22%
Health Care Other Sources$56.0M1%

Related Comparisons